Previous 10 | Next 10 |
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2023 results on Wednesday, November 1, 2023 at 12 p.m. London time (8 a.m. Eastern Time). The Company will release its third-quarter 2023 results prior to the call. ...
2023-09-11 18:15:12 ET Summary Greenlight Capital's 13F portfolio value increased by 16% to $2.13B in Q2 2023. New stakes include Net Power Inc., Activision Blizzard, First Horizon Corp, and Seadrill Ltd. Stake disposals include Global Payments and Civitas Resources, while sta...
2023-09-10 15:17:31 ET HSBC initiated coverage of 11 US biopharma stocks this week, adding IQVIA, Zoetis, bluebird and Actinium Pharmaceuticals to its “buy” ratings list. IQVIA ( NYSE: IQV ) and Zoetis ( NYSE: ZTS ) were labeled “quality growthȁ...
2023-09-04 12:00:00 ET More on AI Cathie Wood's 'Big Ideas 2023' sees Artificial Intelligence as the future Artificial intelligence is a '1995 moment' for tech. That could push stocks even higher Apple CEO Tim Cook says artificial intelligence 'is a major focus of ou...
2023-08-31 08:59:49 ET More on LivaNova LivaNova: Struggling To Eye Value At Current Multiples, Reiterate Hold LivaNova PLC ( LIVN ) Q2 2023 Earnings Call Transcript LivaNova PLC 2023 Q2 - Results - Earnings Call Presentation LivaNova PLC beats Q2 top and...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM) , which provides accurate and continuous measurement of essential bloo...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Bill Kozy, Interim Chief Executive Officer and Board Chair of LivaNova, will present in a fireside chat at the Baird Global Healthcare Conference in New York. The presentation will take place at 12:50 p.m. E...
2023-08-02 02:19:06 ET Summary LivaNova PLC posted mixed Q2 FY'23 results, with growth observed in the P&L and balance sheet. The company's Q2 earnings showed top-line growth and margin decompression on an adjusted basis. Despite this, I'm yet to be convinced based on the ...
2023-07-26 13:10:20 ET LivaNova PLC (LIVN) Q2 2023 Earnings Conference Call July 26, 2023, 08:00 ET Company Participants Matthew Dodds - SVP, Corporate Development & IT William Kozy - Chairman & Interim CEO Alex Shvartsburg - CFO Stephanie Bolton - Pr...
2023-07-26 06:10:09 ET LivaNova PLC press release ( NASDAQ: LIVN ): Q2 Non-GAAP EPS of $0.78 beats by $0.24 . Revenue of $293.9M (+15.6% Y/Y) beats by $28.86M . Full-Year 2023 Guidance: LivaNova now expects revenue for full-year 2023 to grow between 8% an...
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...